Systemic Lupus Erythematodes clinical trials

Explore recruiting systemic lupus erythematodes clinical trials.

Also recruiting in Europe

Systemic Lupus Erythematodes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The effects of rituximab and obinutuzumab on lymphocyte subsets in peripheral blood and lymphoid tissues of SLE patients

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

The effects of belimumab on synovial inflammation and composition of lymph nodes in SLE patients

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Systemic Lupus Erythematodes trials by city

Systemic Lupus Erythematodes in Toronto Systemic Lupus Erythematodes in Vancouver Systemic Lupus Erythematodes in Montreal Systemic Lupus Erythematodes in Calgary Systemic Lupus Erythematodes in Edmonton Systemic Lupus Erythematodes in Ottawa Systemic Lupus Erythematodes in Winnipeg Systemic Lupus Erythematodes in Quebec City Systemic Lupus Erythematodes in Hamilton Systemic Lupus Erythematodes in Kitchener Systemic Lupus Erythematodes in London Systemic Lupus Erythematodes in Halifax Systemic Lupus Erythematodes in New York Systemic Lupus Erythematodes in Los Angeles Systemic Lupus Erythematodes in Chicago Systemic Lupus Erythematodes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease